T2 Biosystems Inc Revenue Y/Y
What is the Revenue Y/Y of T2 Biosystems Inc?
The Revenue Y/Y of T2 Biosystems Inc is -45.74%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to T2 Biosystems Inc
What does T2 Biosystems Inc do?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Companies with revenue y/y similar to T2 Biosystems Inc
- China International Development has Revenue Y/Y of -45.93%
- Twintek Investment has Revenue Y/Y of -45.87%
- Sinopharm Co has Revenue Y/Y of -45.85%
- Sinopharm Co has Revenue Y/Y of -45.85%
- Alector has Revenue Y/Y of -45.84%
- e Gorgé SA has Revenue Y/Y of -45.81%
- T2 Biosystems Inc has Revenue Y/Y of -45.74%
- Dynavax Technologies has Revenue Y/Y of -45.65%
- Evolution Petroleum has Revenue Y/Y of -45.64%
- China SXT Pharmaceuticals Inc has Revenue Y/Y of -45.53%
- Contel Technology has Revenue Y/Y of -45.53%
- Hazer has Revenue Y/Y of -45.49%
- 8K Miles Software Services has Revenue Y/Y of -45.45%